Document is current
Any future updates will be listed below
-
Authors
Felgner, Jiin
Hernandez-Davies, Jenny E.
Strahsburger, Erwin
Silzel, Emily
Nakajima, Rie
Jain, Aarti
Laster, Jacob
Chiang, Jui-Lin
Tsai, Yali
Felgner, Philip L.
Davies, D. Huw
Liang, Li
-
Funding
Funding for this research was provided by:
Polaris Pharmaceuticals, LLC
- License Information
-
More Information
Article History
Received: 19 December 2024
Accepted: 2 May 2025
First Online: 11 June 2025
Competing interests
: P.L.F. is a consultant for Polaris Pharmaceuticals, L.L.C., P.L.F., D.H.D., L.L., J.F., J.E.H. and E.S. have filed patent applications on this and other multivalent mRNA vaccines through the University of California Irvine. The other authors declare no competing interests.
